Literature DB >> 15657416

Direct and indirect interactions between calcineurin-NFAT and MEK1-extracellular signal-regulated kinase 1/2 signaling pathways regulate cardiac gene expression and cellular growth.

Bastiano Sanna1, Orlando F Bueno, Yan-Shan Dai, Benjamin J Wilkins, Jeffery D Molkentin.   

Abstract

MEK1, a member of the mitogen-activated protein kinase (MAPK) cascade that directly activates extracellular signal-regulated kinase (ERK), induces cardiac hypertrophy in transgenic mice. Calcineurin is a calcium-regulated protein phosphatase that also functions as a positive regulator of cardiac hypertrophic growth through a direct mechanism involving activation of nuclear factor of activated T-cell (NFAT) transcription factors. Here we determined that calcineurin-NFAT and MEK1-ERK1/2 signaling pathways are interdependent in cardiomyocytes, where they directly coregulate the hypertrophic growth response. For example, genetic deletion of the calcineurin Abeta gene reduced the hypertrophic response elicited by an activated MEK1 transgene in the heart, while inhibition of calcineurin or NFAT in cultured neonatal cardiomyocytes also blunted the hypertrophic response driven by activated MEK1. Conversely, targeted inhibition of MEK1-ERK1/2 signaling in cultured cardiomyocytes attenuated the hypertrophic growth response directed by activated calcineurin. However, targeted inhibition of MEK1-ERK1/2 signaling did not directly affect calcineurin-NFAT activation, nor was MEK1-ERK1/2 activation altered by targeted inhibition of calcineurin-NFAT. Mechanistically, we show that MEK1-ERK1/2 signaling augments NFAT transcriptional activity independent of calcineurin, independent of changes in NFAT nuclear localization, and independent of alterations in NFAT transactivation potential. In contrast, MEK1-ERK1/2 signaling enhances NFAT-dependent gene expression through an indirect mechanism involving induction of cardiac AP-1 activity, which functions as a necessary NFAT-interacting partner. As a second mechanism, MEK1-ERK1/2 and calcineurin-NFAT proteins form a complex in cardiac myocytes, resulting in direct phosphorylation of NFATc3 within its C terminus. MEK1-ERK1/2-mediated phosphorylation of NFATc3 directly augmented its DNA binding activity, while inhibition of MEK1-ERK1/2 signaling reduced NFATc3 DNA binding activity. Collectively, these results indicate that calcineurin-NFAT and MEK1-ERK1/2 pathways constitute a codependent signaling module in cardiomyocytes that coordinately regulates the growth response through two distinct mechanisms.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15657416      PMCID: PMC544001          DOI: 10.1128/MCB.25.3.865-878.2005

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  62 in total

1.  Affinity-driven peptide selection of an NFAT inhibitor more selective than cyclosporin A.

Authors:  J Aramburu; M B Yaffe; C López-Rodríguez; L C Cantley; P G Hogan; A Rao
Journal:  Science       Date:  1999-09-24       Impact factor: 47.728

2.  Myocyte-enriched calcineurin-interacting protein, MCIP1, inhibits cardiac hypertrophy in vivo.

Authors:  B A Rothermel; T A McKinsey; R B Vega; R L Nicol; P Mammen; J Yang; C L Antos; J M Shelton; R Bassel-Duby; E N Olson; R S Williams
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-13       Impact factor: 11.205

3.  Targeted inhibition of calcineurin attenuates cardiac hypertrophy in vivo.

Authors:  L J De Windt; H W Lim; O F Bueno; Q Liang; U Delling; J C Braz; B J Glascock; T F Kimball; F del Monte; R J Hajjar; J D Molkentin
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-13       Impact factor: 11.205

4.  The MEK1-ERK1/2 signaling pathway promotes compensated cardiac hypertrophy in transgenic mice.

Authors:  O F Bueno; L J De Windt; K M Tymitz; S A Witt; T R Kimball; R Klevitsky; T E Hewett; S P Jones; D J Lefer; C F Peng; R N Kitsis; J D Molkentin
Journal:  EMBO J       Date:  2000-12-01       Impact factor: 11.598

5.  A role for the p38 MAP kinase pathway in the nuclear shuttling of NFATp.

Authors:  P Gómez del Arco; S Martínez-Martínez; J L Maldonado; I Ortega-Pérez; J M Redondo
Journal:  J Biol Chem       Date:  2000-05-05       Impact factor: 5.157

6.  Extracellular signal-regulated kinase plays an essential role in hypertrophic agonists, endothelin-1 and phenylephrine-induced cardiomyocyte hypertrophy.

Authors:  T L Yue; J L Gu; C Wang; A D Reith; J C Lee; R C Mirabile; R Kreutz; Y Wang; B Maleeff; A A Parsons; E H Ohlstein
Journal:  J Biol Chem       Date:  2000-12-01       Impact factor: 5.157

7.  Requirement of activation of the extracellular signal-regulated kinase cascade in myocardial cell hypertrophy.

Authors:  T Ueyama; S Kawashima; T Sakoda; Y Rikitake; T Ishida; M Kawai; T Yamashita; S Ishido; H Hotta; M Yokoyama
Journal:  J Mol Cell Cardiol       Date:  2000-06       Impact factor: 5.000

8.  A protein encoded within the Down syndrome critical region is enriched in striated muscles and inhibits calcineurin signaling.

Authors:  B Rothermel; R B Vega; J Yang; H Wu; R Bassel-Duby; R S Williams
Journal:  J Biol Chem       Date:  2000-03-24       Impact factor: 5.157

9.  DSCR1, overexpressed in Down syndrome, is an inhibitor of calcineurin-mediated signaling pathways.

Authors:  J J Fuentes; L Genescà; T J Kingsbury; K W Cunningham; M Pérez-Riba; X Estivill; S de la Luna
Journal:  Hum Mol Genet       Date:  2000-07-01       Impact factor: 6.150

10.  Glycogen synthase kinase-3beta is a negative regulator of cardiomyocyte hypertrophy.

Authors:  S Haq; G Choukroun; Z B Kang; H Ranu; T Matsui; A Rosenzweig; J D Molkentin; A Alessandrini; J Woodgett; R Hajjar; A Michael; T Force
Journal:  J Cell Biol       Date:  2000-10-02       Impact factor: 10.539

View more
  58 in total

1.  Interaction between NFκB and NFAT coordinates cardiac hypertrophy and pathological remodeling.

Authors:  Qinghang Liu; Yi Chen; Mannix Auger-Messier; Jeffery D Molkentin
Journal:  Circ Res       Date:  2012-03-08       Impact factor: 17.367

2.  Pleiotropic phenotype of a genomic knock-in of an RGS-insensitive G184S Gnai2 allele.

Authors:  Xinyan Huang; Ying Fu; Raelene A Charbeneau; Thomas L Saunders; Douglas K Taylor; Kurt D Hankenson; Mark W Russell; Louis G D'Alecy; Richard R Neubig
Journal:  Mol Cell Biol       Date:  2006-09       Impact factor: 4.272

3.  Noonan syndrome mutation Q79R in Shp2 increases proliferation of valve primordia mesenchymal cells via extracellular signal-regulated kinase 1/2 signaling.

Authors:  Maike Krenz; Katherine E Yutzey; Jeffrey Robbins
Journal:  Circ Res       Date:  2005-09-15       Impact factor: 17.367

Review 4.  Mitogen-activated protein kinases in heart development and diseases.

Authors:  Yibin Wang
Journal:  Circulation       Date:  2007-09-18       Impact factor: 29.690

Review 5.  G protein-dependent and G protein-independent signaling pathways and their impact on cardiac function.

Authors:  Douglas G Tilley
Journal:  Circ Res       Date:  2011-07-08       Impact factor: 17.367

6.  Decoding GnRH neurohormone pulse frequency by convergent signalling modules.

Authors:  Krasimira Tsaneva-Atanasova; Petros Mina; Christopher J Caunt; Stephen P Armstrong; Craig A McArdle
Journal:  J R Soc Interface       Date:  2011-06-15       Impact factor: 4.118

7.  NFAT targets signaling molecules to gene promoters in pancreatic β-cells.

Authors:  Michael C Lawrence; Nofit Borenstein-Auerbach; Kathleen McGlynn; Faisal Kunnathodi; Rauf Shahbazov; Ilham Syed; Mazhar Kanak; Morihito Takita; Marlon F Levy; Bashoo Naziruddin
Journal:  Mol Endocrinol       Date:  2014-12-12

8.  A cardiac-enriched microRNA, miR-378, blocks cardiac hypertrophy by targeting Ras signaling.

Authors:  Raghu S Nagalingam; Nagalingam R Sundaresan; Mahesh P Gupta; David L Geenen; R John Solaro; Madhu Gupta
Journal:  J Biol Chem       Date:  2013-02-27       Impact factor: 5.157

9.  NFAT signalling is a novel target of oncogenic BRAF in metastatic melanoma.

Authors:  R J Flockhart; J L Armstrong; N J Reynolds; P E Lovat
Journal:  Br J Cancer       Date:  2009-09-01       Impact factor: 7.640

10.  Gravity, a regulation factor in the differentiation of rat bone marrow mesenchymal stem cells.

Authors:  Yan Huang; Zhong-Quan Dai; Shu-Kuan Ling; Hong-Yu Zhang; Yu-Min Wan; Ying-Hui Li
Journal:  J Biomed Sci       Date:  2009-09-21       Impact factor: 8.410

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.